Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-15

Clinical Trial Update: APOL1 Genetic Testing Program for Living Donors, Part 2 [NA]

View source ↗

Summary

Northwestern University's APOL1 genetic testing program for living kidney donors (Part 2) has completed its trial update, evaluating APOL1 risk variants and imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwestern University | Conditions: Chronic Kidney Diseases, Genetic Predisposition | NA | Status: COMPLETED